Titan Fund I SPC - Titan Biotech Dislocation Fund SP is a hedge fund based in Stamford, Connecticut. According to its most recent Form D, filed May 8, 2026, the fund has sold $17,699,000 of interests to 33 investors since its first sale in May 2022. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, HedgeMountain classifies it as an emerging manager. Related persons named in the filing include George Fox; Philip Lombino; Frank Stone.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $17,699,000Cumulative sales reported on Form D
- Investors
- 33
- First sale
- May 1, 2022
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- George Fox; Philip Lombino; Frank Stone
- Latest Form D
- May 8, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 23% of the 808 hedge funds based in Connecticut, and more than 28% of all 10,157 that report sales.